share_log

Vincerx Pharma Shares Are Trading Higher After the Company and Oqory Announced Phase 1a/1b Results for Anti-TROP2 ADC OQY-3258 in Solid Tumors. Additionally, There Is a Proposed Merger Between the Two Companies to Advance Phase 2 Trials and Build an...

Benzinga ·  Jan 29 14:23

Vincerx Pharma Shares Are Trading Higher After the Company and Oqory Announced Phase 1a/1b Results for Anti-TROP2 ADC OQY-3258 in Solid Tumors. Additionally, There Is a Proposed Merger Between the Two Companies to Advance Phase 2 Trials and Build an ADC Pipeline

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 1631

Recommended

Write a comment